Gilead Sciences Depreciation & Amortization 2011-2025 | GILD

Annual Depreciation & Amortization Gilead Sciences

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
381 M	354 M	323 M	329 M	288 M	255 M	226 M	233 M	177 M	161 M	125 M	103 M	83 M	72.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
381 M	72.2 M	222 M

Quarterly Depreciation & Amortization Gilead Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
90 M	93 M	97 M	-	94 M	98 M	94 M	-	598 M	598 M	94 M	-	445 M	445 M	80 M	-	239 M	157 M	78 M	-	209 M	136 M	68 M	-	186 M	120 M	60 M	-	169 M	112 M	56 M	-	155 M	103 M	49 M	-	129 M	85 M	42 M	-	116 M	75 M	37 M	-	94 M	53 M	24 M	-	76 M	50.1 M	24 M	-	60.5 M	39.9 M	19.7 M	-	53.2 M	36 M	18.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
598 M	18.3 M	128 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.93	4.78 %	$ 818 M	Canada
Aclaris Therapeutics ACRS	807 K	$ 3.2	-1.69 %	$ 247 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Aptevo Therapeutics APVO	352 K	$ 1.07	-5.75 %	$ 295 K	USA
BioVie BIVI	229 K	$ 1.42	-1.85 %	$ 2.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 26.45	4.67 %	$ 1.28 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	6.43 M	$ 9.6	0.37 %	$ 141 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 0.26	-6.98 %	$ 566 M	Israel
Catalyst Biosciences CBIO	1.07 M	$ 12.98	-7.91 %	$ 854 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	48.4 M	$ 548.58	-2.78 %	$ 41.6 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.37	2.83 %	$ 14.9 M	USA
Celldex Therapeutics CLDX	3.18 M	$ 27.09	-1.53 %	$ 1.74 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 11.33	-1.78 %	$ 733 M	USA
Biogen BIIB	673 M	$ 175.2	0.63 %	$ 25.5 B	USA
Abeona Therapeutics ABEO	2.29 M	$ 5.07	-5.5 %	$ 108 M	USA
Corcept Therapeutics Incorporated CORT	795 K	$ 87.67	-0.36 %	$ 9.05 B	USA
ADiTx Therapeutics ADTX	614 K	$ 1.43	-36.18 %	$ 18.8 K	USA
Cellectar Biosciences CLRB	192 K	$ 3.28	-9.39 %	$ 40.1 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Catalyst Pharmaceuticals CPRX	397 K	$ 24.29	2.84 %	$ 2.88 B	USA